HIV care for Human Immunodeficiency Virus Infection

Phase-Based Progress Estimates
University of Miami, Miami, FLHuman Immunodeficiency Virus Infection+2 MoreHIV care - Other
All Sexes
What conditions do you have?

Study Summary

This trial will test if providing HIV medicine immediately at an IDEA Syringe Services Program will help people with HIV get and stay in care, including having no detectable HIV in their blood.

Eligible Conditions
  • Human Immunodeficiency Virus (HIV) Infection
  • Substance Use
  • Self-Harm

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Study Objectives

0 Primary · 1 Secondary · Reporting Duration: 12 months

12 months
Percentage of participants with HIV viral load suppression

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Trial Design

1 Treatment Group

Rapid ART group
1 of 1

Experimental Treatment

50 Total Participants · 1 Treatment Group

Primary Treatment: HIV care · No Placebo Group · Phase 4

Rapid ART groupExperimental Group · 2 Interventions: HIV care, Biktarvy 50Mg-200Mg-25Mg Tablet · Intervention Types: Other, Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months

Who is running the clinical trial?

University of MiamiLead Sponsor
806 Previous Clinical Trials
387,066 Total Patients Enrolled
Hansel Tookes, MD5.01 ReviewsPrincipal Investigator - University of Miami
University of Miami
5Patient Review
This doctor is amazing — they really make sure you stay healthy and care a lot for their patients.

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

What state do they live in?
What site did they apply to?
University of Miami100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%

How responsive is this trial?

Typically responds via
Phone Call100.0%
Most responsive sites:
  1. University of Miami: < 24 hours
Average response time
  • < 1 Day

Frequently Asked Questions

Is this research initiative currently recruiting participants?

"Affirmative. Perusal of the information available on reveals that this experiment is presently recruiting candidates, beginning from March 4th 2021 and concluding on May 4th 2022. 50 participants are sought after in a single medical centre." - Anonymous Online Contributor

Unverified Answer

Are there any past studies that have focused on HIV treatment?

"Currently, 98 medical trials for HIV care are ongoing with the majority of Phase 3 studies located in Boylston, MA. Across 1610 sites worldwide these clinical experiments are being conducted." - Anonymous Online Contributor

Unverified Answer

What medical issues are typically treated with HIV care?

"Anti-retroviral agents are a major component of HIV care, and this type of treatment has been demonstrated to be effective for patients who have yet to receive medication, lack resistance to darunavir, or suffer from HIV-1." - Anonymous Online Contributor

Unverified Answer

How many participants have voluntarily joined this trial?

"Indeed, information hosted on indicates that this research trial is actively enrolling participants and was first posted on March 4th 2021. The study aims to recruit 50 patients from a single medical site." - Anonymous Online Contributor

Unverified Answer

To what extent does providing HIV care pose risks to individuals?

"The safety of HIV care has been verified in Phase 4 trials and thus earned a rating of 3." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.